Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,381 | -7,329 | -33,940 | -25,420 | -18,165 |
| Depreciation Amortization | 244 | 165 | 649 | 480 | 316 |
| Accounts payable and accrued liabilities | 941 | -1,110 | 831 | 216 | 1,471 |
| Other Working Capital | 398 | -676 | 1,509 | -126 | 569 |
| Other Operating Activity | 530 | 1,858 | 2,005 | 2,133 | 333 |
| Operating Cash Flow | $-13,268 | $-7,092 | $-28,946 | $-22,717 | $-15,476 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -54,217 | 0 | N/A | 0 | N/A |
| Investing Cash Flow | $-54,217 | $N/A | $N/A | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,333 | -583 | N/A | 0 | 0 |
| Common Stock Issued | 57,741 | 2 | 13,720 | 17 | 17 |
| Other Financing Activity | -55 | -44 | 7,055 | 7,017 | 6,883 |
| Financing Cash Flow | $55,353 | $-625 | $20,775 | $7,034 | $6,900 |
| Beginning Cash Position | 36,830 | 36,830 | 45,001 | 45,001 | 45,001 |
| End Cash Position | 24,698 | 29,113 | 36,830 | 29,318 | 36,425 |
| Net Cash Flow | $-12,132 | $-7,717 | $-8,171 | $-15,683 | $-8,576 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,268 | -7,092 | -28,946 | -22,717 | -15,476 |
| Free Cash Flow | -13,268 | -7,092 | -28,946 | -22,717 | -15,476 |